Rapha Capital Management is a venture capital firm in Miami that focuses on medicine, healthcare and technology. Founded in Miami, Florida, United States by Kevin Slawin, it invests in series C and convertible notes. Its portfolio companies include Poseida Therapeutics, and AsclepiX Therapeutics. Poseida Therapeutics utilizes best-in-class genome engineering capabilities to develop targeted lifesaving therapeutics. AsclepiX Therapeutics is a biotech company that develops novel therapeutics to revolutionize the treatment of retinal diseases and cancer. As of March 2020, Rapha Capital Management has made two investments. Their most recent investment was on April 22, 2019, when Poseida Therapeutics raised $142M.
Timeline
I, LP, is solely focused on investment in early-stage life science companies. The fund will focus on securing the investment lead, typically at Series A or just before, in target companies.
Kevin Slawin, MD, the Founder and Managing Partner of Rapha Capital Management, LLC is an oncologic and robotic surgeon, biotech consultant, investor, and founder focusing on disruptive technologies in oncology, T cells and immunotherapy, as well as other breakthrough healthcare technologies.
People
Kevin Slawin
Founder
Further reading
Documentaries, videos and podcasts
Companies
AsclepiX Therapeutics
Poseida Therapeutics
News
References
Venture capital firm
CompanyCompany attributes
MiamiVenture Capital Firm attributes
ControlRad Systems
Poseida Therapeutics
AsclepiX TherapeuticsCategories
Related Topics
Contributors
- 1
Marie Gabrielle Laguna- Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur - 2
Melanie Manipula
Helping organize knowledge. - 3
Edita Rexha
Economist - 4
Henry Ogolla
Passionate about reading and writing. - 5
Aime Anne Nisay
QA Engineer of web and mobile applications - 6
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME